Ausgabe 2/2014
Inhalt (20 Artikel)
What is the future of magnetic nanoparticles in the axillary management of breast cancer?
M. Ahmed, M. Douek
The effects of exercise on cardiovascular outcomes before, during, and after treatment for breast cancer
Kathleen M. Sturgeon, Bonnie Ky, Joseph R. Libonati, Kathryn H. Schmitz
Osteolysis and pain due to experimental bone metastases are improved by treatment with rapamycin
Dareen M. Abdelaziz, Laura S. Stone, Svetlana V. Komarova
Inhibition of LINE-1 retrotransposon-encoded reverse transcriptase modulates the expression of cell differentiation genes in breast cancer cells
Radhika Patnala, Sung-Hun Lee, Jane E. Dahlstrom, Stephen Ohms, Long Chen, S. Thameem Dheen, Danny Rangasamy
Spinal IFN-γ-induced protein-10 (CXCL10) mediates metastatic breast cancer-induced bone pain by activation of microglia in rat models
Huilian Bu, Bin Shu, Feng Gao, Cheng Liu, Xuehai Guan, Changbin Ke, Fei Cao, Antentor Othrell Hinton Jr., Hongbing Xiang, Hui Yang, Xuebi Tian, Yuke Tian
CXCL13–CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis
Subir Biswas, Suman Sengupta, Sougata Roy Chowdhury, Samir Jana, Gunjan Mandal, Palash Kumar Mandal, Nipun Saha, Vivek Malhotra, Arnab Gupta, Dmitry V. Kuprash, Arindam Bhattacharyya
Hyaluronan synthases (HAS1–3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival
Päivi Auvinen, Kirsi Rilla, Ritva Tumelius, Markku Tammi, Reijo Sironen, Ylermi Soini, Veli-Matti Kosma, Arto Mannermaa, Jukka Viikari, Raija Tammi
Sorcin silencing inhibits epithelial-to-mesenchymal transition and suppresses breast cancer metastasis in vivo
Yunhui Hu, Shuangjing Li, Ming Yang, Cihui Yan, Dongmei Fan, Yuan Zhou, Yanjun Zhang, Ernesto Yagüe, Dongsheng Xiong
Identifying molecular features that distinguish fluvastatin-sensitive breast tumor cells
Carolyn A. Goard, Michelle Chan-Seng-Yue, Peter J. Mullen, Ariel D. Quiroga, Amanda R. Wasylishen, James W. Clendening, Dorota H. S. Sendorek, Syed Haider, Richard Lehner, Paul C. Boutros, Linda Z. Penn
Sixteen years follow-up results of a randomized phase II trial of neoadjuvant fluorouracil, doxorubicin, and cyclophosphamide (FAC) compared with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in stage III breast cancer: GOCS experience
José Pablo Leone, Julieta Leone, Carlos Teodoro Vallejo, Juan Eduardo Pérez, Alberto Omar Romero, Mario Raul Machiavelli, Luis Romero Acuña, María Ester Domínguez, Mario Langui, Hebe Margot Fasce, Bernardo Amadeo Leone, Eduardo Ortiz, Julián Iturbe, Ariel Osvaldo Zwenger
A phase II study of combined fulvestrant and everolimus in patients with metastatic estrogen receptor (ER)-positive breast cancer after aromatase inhibitor (AI) failure
Suleiman Massarweh, Edward Romond, Esther P. Black, Emily Van Meter, Brent Shelton, Vera Kadamyan-Melkumian, Mark Stevens, Richard Elledge
Near-infrared fluorescence sentinel lymph node mapping in breast cancer: a multicenter experience
Floris P. R. Verbeek, Susan L. Troyan, J. Sven D. Mieog, Gerrit-Jan Liefers, Lorissa A. Moffitt, Mireille Rosenberg, Judith Hirshfield-Bartek, Sylvain Gioux, Cornelis J. H. van de Velde, Alexander L. Vahrmeijer, John V. Frangioni
Eight-year update of a prospective study of wide excision alone for small low- or intermediate-grade ductal carcinoma in situ (DCIS)
Julia S. Wong, Yu-Hui Chen, Michele A. Gadd, Rebecca Gelman, Susan C. Lester, Stuart J. Schnitt, Dennis C. Sgroi, Barbara J. Silver, Barbara L. Smith, Susan L. Troyan, Jay R. Harris
A phase II study of docetaxel and vinorelbine plus filgrastim for HER-2 negative, stage IV breast cancer: SWOG S0102
Julie R. Gralow, William E. Barlow, Danika Lew, Kim Dammann, George Somlo, Kristine J. Rinn, Stanley J. Vogel, Lucas Wong, Robert B. Livingston, Gabriel N. Hortobagyi
Impact of full-field digital mammography on pre-operative diagnosis and surgical treatment of mammographic microcalcification
S. M. Bundred, J. Zhou, S. Whiteside, J. Morris, M. Wilson, E. Hurley, N. Bundred
Breast cancer screening of women aged 70–74 years: results from a natural experiment across Australia
Carolyn Nickson, Kate E. Mason, Anne M. Kavanagh
Prospective associations of depression with survival: a population-based cohort study in patients with newly diagnosed breast cancer
Andrea Vodermaier, Wolfgang Linden, Katerina Rnic, Sandra N. Young, Alvina Ng, Nina Ditsch, Robert Olson
Mutations in EGFR, BRAF and RAS are rare in triple-negative and basal-like breast cancers from Caucasian women
E. Tilch, T. Seidens, S. Cocciardi, L. E. Reid, D. Byrne, P. T. Simpson, A. C. Vargas, M. C. Cummings, S. B. Fox, S. R. Lakhani, G. Chenevix Trench
The role of genes co-amplified with nicastrin in breast invasive carcinoma
A. Sarajlić, A. Filipović, V. Janjić, R. C. Coombes, N. Pržulj
Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers
Mitsuya Itoh, Takayuki Iwamoto, Junji Matsuoka, Tomohiro Nogami, Takayuki Motoki, Tadahiko Shien, Naruto Taira, Naoki Niikura, Naoki Hayashi, Shoichiro Ohtani, Kenji Higaki, Toshiyoshi Fujiwara, Hiroyoshi Doihara, W. Fraser Symmans, Lajos Pusztai